BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 10837064)

  • 1. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
    Fearon DT; Carroll MC
    Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 3. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
    Fearon DT; Carter RH
    Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement system and adaptive immunity.
    Fearon DT
    Semin Immunol; 1998 Oct; 10(5):355-61. PubMed ID: 9799710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B cell activated co-receptor].
    Ruan X; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):436-9. PubMed ID: 12905672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-receptors on B lymphocytes.
    Tsubata T
    Curr Opin Immunol; 1999 Jun; 11(3):249-55. PubMed ID: 10375550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
    Smith AJ; Gordon TP; Macardle PJ
    Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-receptors of B lymphocytes.
    O'Rourke L; Tooze R; Fearon DT
    Curr Opin Immunol; 1997 Jun; 9(3):324-9. PubMed ID: 9203413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
    J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
    Sato S; Miller AS; Howard MC; Tedder TF
    J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.